Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Burkitt Lymphoma × Injections × Clear all

Phase

Status

Sponsor Class

OTHER_GOV 1 OTHER 1 NETWORK 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Triple Negative Breast Neoplasms 2 Uterine Cervical Neoplasms 1 Stomach Neoplasms 1 Solid Tumor 1 Neuroendocrine Tumors 1 Intestinal Neoplasms 1 Hematopoietic Recovery 1 HER2 Low Breast Carcinoma 1 Burkitt Lymphoma 1 Breast Neoplasms 1 Adenoma, Islet Cell 1

Interventions

fludarabine 3 Cyclophosphamide 3 fludarabine phosphate 1 Injections 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06056752 2023-10-24

QH103 Cell Injection for the Treatment of Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia

Anhui Provincial Hospital

Phase 1 Recruiting

Burkitt Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡